Over Rs 2 Cr Semaglutide Theft at Dr Reddy's Srikakulam Unit, Staff Among 8 Arrested Farhat Nasim13 Jun 2025 6:17 PM ISTSrikakulam: In a serious breach of supply chain and internal controls, a group of eight individuals, including current and former pharmaceutical...
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy Ruchika Sharma7 Jun 2025 4:52 PM ISTEuropean Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns...
Delhi HC Restrains Dr Reddy's from Selling Semaglutide Drug in India Amid Novo Nordisk Row Ruchika Sharma31 May 2025 6:19 PM ISTNovo Nordisk has accused Dr Reddy's and OneSource of importing semaglutide API and using it to make and export formulations.
WHO to back use of weight-loss drugs as obesity treatment in adults Ruchika Sharma5 May 2025 11:00 AM ISTLondon: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity in adults for the...
Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 3:21 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
Sun Pharma eyes to launch obesity drug in five years: MD Ruchika Sharma1 March 2025 2:34 PM ISTMumbai: Pharma major, Sun Pharmaceutical, is gearing up to introduce its experimental anti-obesity and type 2 diabetes medicine in the next...
Semaglutide shows promise in reducing cravings for alcohol, heavy drinking, finds study Dr. Kamal Kant Kohli14 Feb 2025 8:15 AM ISTThe blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol...
Phase 2b QUALITY Trial: Enobosarm Significantly Reduces Lean Mass Loss in Patients on Semaglutide Dr. Kamal Kant Kohli31 Jan 2025 9:30 AM ISTEnobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients Farhat Nasim20 Nov 2024 1:36 PM ISTThe move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has yet to launch it.
